Inhibitex (INHX) Trudges Higher, Now Down ~20%; Dec./Jan. Puts Draw Interest
Tweet
Share
E-mailGet Alerts INHX Hot Sheet
Join SI Premium – FREE
After being down as much as 36.6 percent Friday following Pharmasset amending its QUANTUM trial, Inhibitex (Nasdaq: INHX) are comfortably off of lows.
Shares are now down just over 20 percent, to $10.32 per share.
Notably, the price of December 12.5 put options ripped 1400 percent higher today, the last sale at $2.25.
Shares are now down just over 20 percent, to $10.32 per share.
Notably, the price of December 12.5 put options ripped 1400 percent higher today, the last sale at $2.25.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) call put ratio 4.2 calls to 1 put with a focus on September 4.5 and 5 calls into quarter results
- Science Applications Int'l (SAIC) November 135 puts active, share price up 3.5%
- Popular stocks with increasing option volume: MU SPCX PCG INTC SOFI PLTR MSTR AVGO GME MRVL
Create E-mail Alert Related Categories
Insiders' Blog, OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
